Histone serotonylation regulates ependymoma tumorigenesis

Area of Science:

• Neuro-oncology
• Epigenetics
• Cancer Biology

Background:

• Tumor cells communicate with neurons, influencing the tumor microenvironment and malignancy.
• Epigenomic dysregulation is a hallmark of cancer, affecting gene expression and cell interactions.
• Ependymoma (EPN) is a pediatric brain tumor driven by epigenomic remodeling, but its interaction with neuronal signaling is unclear.

Purpose of the Study:

• To investigate the intersection of epigenetic mechanisms and neuronal signaling in pediatric ependymoma progression.
• To identify novel therapeutic targets by understanding the molecular drivers of ependymoma.

Main Methods:

• Analysis of bidirectional communication between tumors and neurons.
• Investigation of epigenomic dysregulation in cancer.
• In vivo screening of transcription factors.
• Histone modification analysis.

Main Results:

• Serotonergic neuron activity and serotonin itself regulate ependymoma tumorigenesis via histone serotonylation.
• Inhibiting histone serotonylation blocks ependymoma growth and alters developmental transcription factor expression.
• ETV5 promotes ependymoma by enhancing repressive chromatin, while Neuropeptide Y (NPY) suppresses tumor progression.

Conclusions:

• Histone serotonylation is a critical driver of ependymoma tumorigenesis.
• Neuronal signaling, neuro-epigenomics, and developmental programs are interconnected in driving brain cancer malignancy.
• Targeting histone serotonylation or specific transcription factors presents potential therapeutic strategies for ependymoma.